The President's Council on Bioethics click here to skip navigation

 

Reproduction and Responsibility Small Report Cover

Reproduction and Responsibility: The Regulation of New Biotechnologies

The President's Council on Bioethics
Washington, D.C., March 2004
If you are interested in ordering a report, please send requests with the name of the report and your full mailing address to info@bioethics.gov. Please allow 6 to 8 weeks for delivery.

TABLE OF CONTENTS

Detailed Table of Contents

1   Introduction   

I. Background
II. The Domain of Inquiry
III. The Human Goods At Stake
IV. Some Specific Issues
V. The American Legal Landscape
VI.
 The Character and Significance of Human Procreation
VII.
 Brief Outline of the Report
  Footnotes
  Endnote

2   Assisted Reproduction                                          

I. Techniques and Practices
II. Ethical Considerations
III. Current Regulation
IV. Conclusion
  Footnotes
  Endnotes

3   Screening and Selection for Genetic Conditions and Traits

I. Uses and Techniques
II. Ethical Considerations
III. Regulation
IV. Conclusion
V. Societal Significance and Public Responsibility
  Footnotes
  Endnotes

4   Modification of Traits and Characteristics                                                               

I. Techniques and Practices
II. Ethical Considerations
III. Current Regulation
IV. Conclusion
  Footnotes
  Endnotes

5 Research Involving In Vitro Human Embryos
I.

Techniques and Practices
II. Ethical Considerations
III. Regulation
IV. Conclusion
  Footnotes
  Endnotes

6 Commerce
I.

Gametes and Embryos
II. Sale of ART Services
III. Patenting Human Organisms
IV. Conclusion
  Footnotes
  Endnotes

7 Diagnostic Survey: Summary and Conclusion
I.

Summary
II. Conclusion
  Footnotes

8 Findings
I.

Domain of Inquiry
II. General Conclusions
  Footnotes

9 Policy Options
I.

Institutional Options

II. Substantive Options
III. Conclusion
  Footnotes

10 Recommendations
I.

Federal Studies, Data Collection, Reporting, and Monitoring Regarding the Uses and Effects of These Technologies
II. Increased Oversight By Professional Societies and Practitioners
III. Targeted Legislative Measures
  Footnotes

Appendix
  Statement of Rebecca S. Dresser, J.D., M.S.; Mary Ann Glendon, J.D., M.Comp.L.; Charles Krauthammer, M.D.; and James Q. Wilson, Ph.D.
  Statement of Rebecca S. Dresser, J.D., M.S. 
  Statement of Daniel W. Foster, M.D.; Michael S. Gazzaniga, Ph.D.; Janet D. Rowley, M.D.; Michael J. Sandel, D.Phil.; and James Q. Wilson, Ph.D. 
  Statement of Francis Fukuyama, Ph.D. and James Q. Wilson, Ph.D.
  Statement of Michael S. Gazzaniga, Ph.D.    
  Statement of Robert P. George, J.D., D.Phil; Mary Ann Glendon, J.D., M.Comp.L.; Alfonso Gómez-Lobo, Dr. phil.; William B. Hurlbut, M.D.; and Gilbert C. Meilaender, Ph.D.    
  Statement of Robert P. George, J.D., D.Phil; and Alfonso Gómez-Lobo, Dr. phil. 
  Statement of Leon R. Kass, M.D., Ph.D.    
  Statement of Paul McHugh, M.D.
  Statement of Janet D. Rowley, M.D.

 

 
  - The President's Council on Bioethics -  
 
Home Site Map Disclaimers Privacy Notice Accessibility Contact Us
NBAC HHS —Download Acrobat Reader Acrobat Reader Icon

White House Logo